increased mammary adenocarcinoma incidence_Tg(MMTV-rtTA)1Lach/0,Tg(tetO-ERBB2)#Jjz/0

http://metadb.riken.jp/0001883IFVBNTgMMTVrtTA1Lach0TgtetOERBB2Jjz0TgtetOERBB2JjzTgMMTVrtTA1Lach

increased mammary adenocarcinoma incidence_Tg(MMTV-rtTA)1Lach/0,Tg(tetO-ERBB2)#Jjz/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion 1, Lewis A Chodosh
  http://metadb.riken.jp/db/mgi_rdf/MGI:3511873
• transgene insertion, Jean J Zhao
  http://metadb.riken.jp/db/mgi_rdf/MGI:5775595

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(MMTV-rtTA)1Lach/0,Tg(tetO-ERBB2)#Jjz/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(tetO-ERBB2)#Jjz|Tg(MMTV-rtTA)1Lach

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: FVB/N

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased mammary adenocarcinoma incidence
  http://purl.obolibrary.org/obo/MP_0001883

文献

http://purl.org/net/cito/citesAsAuthority

• Shom. Goel, et.al., Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors., Cancer cell, 2016, 29
  http://rdf.ncbi.nlm.nih.gov/pubmed/26977878